TRYP THERAPEUTICS INC is a clinical stage drug development company led by a management team with extensive drug development experience developing a diversified portfolio of product candidates targeting neuropsychiatric and oncology indications with high unmet medical needs.In February 2022, Tryp Therapeutics Inc had announced a non-brokered private placement consists of 11,111,111 million units at a price of $0.18 per Unit, to raise gross proceeds of approximately $2.0 million.In February 2021, Tryp Therapeutics Inc had announced a non-brokered private placement of 3,333,333 million units at a price of $0.60 per Unit, to raise gross proceeds of approximately $2.0 million